Welcome to our dedicated page for GENWORTH FINANCIAL SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Genworth Financial, Inc. filings document formal earnings disclosures for an insurance holding company with Enact mortgage insurance operations and a Closed Block of long-term care insurance, life insurance and annuity products. Recent Form 8-K reports furnish quarterly results press releases and financial supplements under Item 2.02.
The filings also record Genworth’s references to Enact Holdings as a publicly traded subsidiary, segment-level reporting context, conference-call notices and exhibit-based financial materials. These disclosures connect reported results to mortgage insurance performance, legacy insurance liabilities, investment impacts and holding-company capital actions.
Genworth Financial EVP & Chief Financial Officer Jerome T. Upton reported equity award activity involving restricted stock units and common shares. On February 13, 2026, 36,486 Restricted Stock Units vested and were converted into 36,486 shares of Common Stock on a 1:1 basis at no exercise price. To cover tax withholding on this vesting, 9,701 shares of Common Stock were disposed of at $8.92 per share through share withholding rather than an open-market sale. After these transactions, Upton directly owned 454,773 shares of Genworth Financial common stock.
Genworth Financial EVP & Chief Investment Officer Kelly A. Saltzgaber reported equity award activity. On February 13, 2026, 21,892 Restricted Stock Units were exercised and converted into 21,892 shares of Common Stock at $0.00 per share. To cover tax withholding on the vested units, 6,195 Common shares were withheld at $8.92 per share, leaving Saltzgaber with direct ownership of 68,272 Common shares.
Genworth Financial executive vice president and general counsel Gregory S. Karawan reported equity award activity involving restricted stock units and common shares. On February 13, 2026, 21,892 restricted stock units were exercised and converted to 21,892 shares of common stock at a stated price of $0.00 per share, reflecting a vesting event rather than an open-market purchase.
To cover related tax withholding on the vested units, 6,076 common shares were withheld at $8.92 per share. After these transactions, Karawan directly owned 317,816 shares of Genworth common stock and also had an additional 4,731.743 shares held indirectly through a 401(k) plan.
Genworth Financial executive Mark Blakeley Hodges reported equity compensation activity involving restricted stock units and common shares. On February 13, 2026, 21,892 restricted stock units vested and were converted into 21,892 shares of common stock at no exercise price, increasing his direct holdings. The company then withheld 7,284 common shares, valued at $8.92 per share, to cover associated tax obligations. After these transactions, Hodges directly held 110,824 common shares, with an additional 4,526.476 shares held indirectly through a 401(k) plan.
Genworth Financial EVP and Chief HR Officer Melissa Hagerman reported equity compensation activity involving company stock. On February 13, 2026, 21,892 Restricted Stock Units were exercised and converted into 21,892 shares of common stock at $0.00 per share. To cover related tax withholding on the vested units, 7,184 common shares were disposed of at $8.92 per share. After these transactions, Hagerman directly owned 148,279 shares of Genworth Financial common stock.
Genworth Financial executive Jamala M. Arland, Pres. & CEO, U.S. Life Insurance, reported equity award activity. On February 13, 2026, 10,946 Restricted Stock Units vested and converted into 10,946 shares of Common Stock. The company then withheld 3,843 shares to cover tax obligations, leaving Arland with 48,010 shares of Common Stock held directly.
Donald Smith & Co., Inc. filed a Schedule 13G reporting beneficial ownership of 23,775,853 shares, or 5.95% of Genworth Financial Inc. common stock as of 12/31/2025. The filing is made on behalf of Donald Smith & Co., Inc. and DSCO Value Fund, L.P.
The shares are held for institutional clients in the ordinary course of business, not to change or influence control of Genworth. Donald Smith & Co., Inc. has sole voting power over 23,048,510 shares and sole dispositive power over 23,546,280 shares, with no shared voting or dispositive power reported.
Genworth Financial, Inc. filed a current report describing recent earnings-related announcements. Its publicly traded subsidiary, Enact Holdings, Inc. (Nasdaq: ACT), issued a press release with financial results for the quarter ended December 31, 2025, furnished as Exhibit 99.1.
Genworth also stated it will release its own earnings for the same quarter after the market closes on February 23, 2026, and will host a conference call on February 24, 2026 at 9:00 a.m. Eastern Time to discuss those results.
Genworth Financial Inc filed a Form 13F reporting institutional holdings with a total reported market value of $445,813,658. The report lists 2 information‑table entries and was signed by Darren W. Woodell, Vice President and Controller, on 01-23-2026.
Genworth Financial Inc. reported an insider stock transaction by its President and CEO, who is also a director. On December 2, 2025, the reporting person sold 40,000 shares of Genworth common stock at a price of $8.64 per share. After this sale, the reporting person beneficially owned 5,107,444 shares directly and 89,456 shares indirectly through trusts for the benefit of his children.
The filing notes that earlier in the year, on May 30, 2025, a grantor retained annuity trust (GRAT) terminated, resulting in 419,534 shares moving into the reporting person’s direct ownership and 89,456 shares being transferred to children’s trusts. The form also allows for the indication that the transaction may have been made under a pre-arranged Rule 10b5-1 trading plan.